Home » Topics » Regulatory

Regulatory
RSS

FDA approves Dupixent as add-on maintenance therapy for asthma

Oct. 22, 2018

FDA approves Talzenna for germline BRCA-mutated HER2-negative breast cancer

Oct. 17, 2018

FDA approves Yutiq for chronic noninfectious posterior segment uveitis

Oct. 15, 2018

Revcovi approved in U.S. for ADA-SCID

Oct. 8, 2018

FDA approves Nuzyra for CABP and ABSSSI

Oct. 3, 2018

FDA approves Seysara for acne

Oct. 3, 2018

FDA grants accelerated approval to Arikayce for MAC lung disease

Oct. 1, 2018

FDA approves Libtayo for cutaneous squamous cell carcinoma

Oct. 1, 2018

FDA approves Fycompa for partial-onset seizures in pediatric patients

Oct. 1, 2018

Sanwa Kagaku Kenkyusho obtains approval for Metoana in Japan

Oct. 1, 2018